US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CRO Concept

2,309.94

-71.1179-2.99%

Number of Gainers:- -

Number of Losers:2

Number of Flat:- -

PE:- -

High:2,380.49

Open:2,374.41

Low:2,296.77

Close:2,381.06

Volume:2.30M

Turnover:624.86M

Market Cap:56.61B

Float Cap:52.91B

Loading ...

Labcorp Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Centene Corp. Stock Underperforms Thursday When Compared to Competitors

Charles River Labs Price Target Announced at $357.00/Share by UBS

IQVIA Holdings Inc. : UBS Raises Target Price to $345 from $240

THOMSON REUTERS

Press Release: IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026

PMGC Unit Working With Charles River Laboratories for Muscle Health Probiotic Testing

MT Newswires Live

NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs

IQVIA Holdings Inc. : Baird Raises Target Price to $324 from $287

THOMSON REUTERS

Centene Corp. Stock Outperforms Competitors on Strong Trading Day

France's Genfit H1 Revenue Falls Due to Absence of Milestone Payments

Charles River price target raised to $330 from $300 at BofA

Analysts Offer Insights on Healthcare Companies: Xencor (XNCR) and IQVIA Holdings (IQV)

Strategic Minerals gets $9.2M Department of War funding for UK tungsten project

Charles River Laboratories International, Inc. : Jefferies Raises Target Price to $340 from $305

THOMSON REUTERS

Gartner Inc. Stock Rises 4.8%, Outperforms Peers

Charles River Laboratories's DAS Segment Faces Largest Margin Upside, RBC Says

MT Newswires Live

Charles River Labs is Maintained at Overweight by Barclays

Charles River price target raised to $295 from $264 at Mizuho

Charles River Laboratories : Deutsche Bank Raises Target Price to $320 from $300

THOMSON REUTERS

Crossject Expands Executive Board to Five with Lacombe, Morin, Seltz Appointments

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BK4530/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4530","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","market":"US","secType":"PLATE","nameCN":"CRO Concept","latestPrice":2309.9387,"timestamp":1790884799999,"preClose":2381.0566,"halted":0,"volume":2300039,"delay":0,"changeRate":-0.029868,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-71.11792,"latestTime":"10-01 16:00:00 EDT","open":2374.4084,"high":2380.4905,"low":2296.773,"amount":624855031.397602,"amplitude":0.03516,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.481734,"peRate":51.387938,"turnoverRate":0.011605,"increases":0,"decrements":2,"flats":0,"marketCap":56607453184,"floatMarketCap":52905897984},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","high":2380.4905,"amplitude":0.03516,"preClose":2381.0566,"low":2296.773,"pbRate":"6.481734","latestPrice":2309.9387,"volume":2300039,"delay":0,"open":2374.4084,"prevYearClose":1899.2574,"prevWeekClose":2382.3276,"prevMonthClose":2381.0566,"prevQuarterClose":2381.0566,"fiveDayClose":2420.8926,"twentyDayClose":2341.1746,"sixtyDayClose":1802.1345,"secType":"PLATE","market":"US","turnoverRate":0.011605,"peRate":51.387938,"marketCap":56607453184,"floatMarketCap":52905897984,"timestamp":1790884799999,"nameCN":"CRO Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4530\",,,,undefined,":{"bkCode":"BK4530","up":0,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4530\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672476274","title":"Labcorp Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2672476274","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672476274?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:00","pubTimestamp":1790888400,"startTime":"0","endTime":"0","summary":"DJ Labcorp Holdings Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Labcorp Holdings Inc.  slipped 1.14% to $304.60 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.19% to 7,666.45 and the Dow Jones Industrial Average  rising 0.04% to 50,926.56.This was the stock's fourth consecutive day of losses.Labcorp Holdings Inc. closed 10.88% below its 52-week high of $341.80, which the company achieved on August 27th.Despite its losses, the stock outperformed some of its competitors Thursday, as IQVIA Holdings Inc.  fell 3.02% to $260.72, Centene Corp.  fell 1.82% to $60.99, and Teladoc Health Inc.  fell 2.24% to $5.67.Trading volume  remained 207,368 below its 50-day average volume of 765,899.Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1261432733.SGD","HEAL","BK4550","LU0048573561.USD","LU2362540622.SGD","IQV","CNCG","LU1791710582.SGD","LU0477156953.USD","LU0648001328.SGD","LU1201861165.SGD","LU0130517989.USD","LH","BK4167","BK4585","LU0980610538.SGD","BK4154","LU2065170008.USD","LU2362541513.USD","BK4196","LU2237438978.USD","LU1989764664.SGD","LU0528227936.USD","LU1699723380.USD","LU0130103400.USD","LU1861558580.USD","IE0034235188.USD","LU2065171311.SGD","LU2357627491.SGD","LU1059921491.USD","LU0130102774.USD","LU0251131958.USD","LU1791710400.SGD","BK4121","LU0477156797.USD","LU0882574055.USD","BK4548","BK4530","LU0859254822.USD","BK4588","LU1861559042.SGD","EKG","LU0130518102.USD","LU2065169927.USD","LU2065171402.SGD","LU2362541273.HKD","BK4504","CNC","TDOC","LU0006061336.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672376224","title":"Centene Corp. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672376224","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672376224?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:56","pubTimestamp":1790888160,"startTime":"0","endTime":"0","summary":"DJ Centene Corp. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Centene Corp.  shed 1.82% to $60.99 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.19% to 7,666.45 and the Dow Jones Industrial Average  rising 0.04% to 50,926.56.This was the stock's third consecutive day of losses.Centene Corp. closed 12.41% short of its 52-week high of $69.63, which the company achieved on September 14th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as HCA Healthcare Inc.  fell 0.79% to $423.39, IQVIA Holdings Inc.  fell 3.02% to $260.72, and Labcorp Holdings Inc.  fell 1.14% to $304.60.Trading volume  eclipsed its 50-day average volume of 4.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 1, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0251142724.SGD","LU0130103400.USD","LU2355687059.USD","SG9999014021.USD","IE00B3S45H60.SGD","IE0034235188.USD","LH","IHF","LU0742534661.SGD","LU2362541273.HKD","LU1084165304.USD","BK4504","EKG","LU0203347892.USD","LU0859254822.USD","LU1150488218.USD","LU1989764664.SGD","LU2362541513.USD","CNCG","LU0211327993.USD","LU0130518102.USD","LU1267930573.SGD","LU2357627491.SGD","LU0114720955.EUR","LU0433182093.SGD","HCA","BK4185","LU0251131958.USD","CNC","LU2065170008.USD","SG9999014005.SGD","BK4585","LU2362540622.SGD","SG9999014039.USD","LU0128525929.USD","HEAL","LU0068578508.USD","IQV","BK4196","LU1267930490.SGD","LU0882574055.USD","LU1261432733.SGD","LU1489326972.SGD","LU1791710400.SGD","BK4530","LU0310799852.SGD","LU1989764748.USD","LU0477156797.USD","LU0985489474.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671520234","title":"Charles River Labs Price Target Announced at $357.00/Share by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2671520234","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671520234?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:50","pubTimestamp":1790772600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRL/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BFMHRM44.USD","BK4121","LU0390134368.USD","BK4530","LU0128526141.USD","LU0757428866.USD","BK4585","LU1815336091.USD","CRL","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671044282","title":"IQVIA Holdings Inc. : UBS Raises Target Price to $345 from $240","url":"https://stock-news.laohu8.com/highlight/detail?id=2671044282","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671044282?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:38","pubTimestamp":1790771912,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nAZN4TMTVT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0980610538.SGD","BK4588","LU0130518102.USD","LU1791710400.SGD","LU0130102774.USD","LU0477156797.USD","LU0648001328.SGD","BK4530","LU0648000940.SGD","LU1989764664.SGD","BK4585","BK4121","LU0198837287.USD","LU0882574055.USD","LU0477156953.USD","EKG","LU1791710582.SGD","LU0528227936.USD","LU1261432733.SGD","IQV","LU0130517989.USD","LU1201861249.SGD","LU1201861165.SGD","HEAL","LU1989764748.USD","LU0130103400.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671735242","title":"Press Release: IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671735242","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671735242?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:15","pubTimestamp":1790712900,"startTime":"0","endTime":"0","summary":"RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--September 29, 2026--IQVIA Holdings Inc. (\"IQVIA\") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","IQV","BK4232","BK4550","LU1261432733.SGD","03160","NOBL","LU1791710400.SGD","IXJ","LU0528227936.USD","BK4022","EKG","LU0130518102.USD","TCAF","BK4555","HEAL","LU0648001328.SGD","LU0477156797.USD","LU1791710582.SGD","TM","BK4588","LU0882574055.USD","LU1989764748.USD","LU0130102774.USD","BK4121","LU1989764664.SGD","LU0130517989.USD","LU1201861165.SGD","VHT","LU0130103400.USD","CGCV","LU1201861249.SGD","LU0980610538.SGD","R","BK4585","LU0477156953.USD","BK4099","LU0648000940.SGD","LU0198837287.USD","BK4530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671940214","title":"PMGC Unit Working With Charles River Laboratories for Muscle Health Probiotic Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2671940214","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671940214?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:34","pubTimestamp":1790685298,"startTime":"0","endTime":"0","summary":"PMGC Holdings  said Tuesday its NorthStrive Biosciences unit entered into an agreement with Charles River Laboratories  to perform analytical testing for two engineered probiotic programs.The program aims to support manufacturing consistency for the EL-22 and EL-32 candidates, which are probiotics designed to maintain muscle health in patients receiving GLP-1 weight loss treatments, as they advance toward clinical trial preparation, the company said.Charles River will conduct testing to measure plasmid copy numbers in the bacterial product candidates.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128526141.USD","LU1815336091.USD","BK4183","LU0390134368.USD","BK4588","BK7095","BK4530","LU0757428866.USD","CRL","CRL.AU","ELAB","IE00BFMHRM44.USD","BK4121","LU0029874061.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671219608","title":"NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2671219608","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671219608?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:33","pubTimestamp":1790681580,"startTime":"0","endTime":"0","summary":"Engagement of a leading global contract research organization strengthens the analytical foundation supporting EL-22 and EL-32 as the programs advance toward an IND-enabling development frameworkBuild","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/29/3370716/0/en/northstrive-biosciences-partners-with-charles-river-laboratories-to-advance-its-el-22-and-el-32-engineered-probiotic-programs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4530","BK4588","BK4585","EES","LU0029874061.USD","CRL","IE00BFMHRM44.USD","LU0757428866.USD","LU1815336091.USD","BK4121","LU0390134368.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671982392","title":"IQVIA Holdings Inc. : Baird Raises Target Price to $324 from $287","url":"https://stock-news.laohu8.com/highlight/detail?id=2671982392","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671982392?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:11","pubTimestamp":1790658700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L0E8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HEAL","LU0130518102.USD","BK4588","LU0648000940.SGD","LU1261432733.SGD","LU0882574055.USD","LU0198837287.USD","BK4530","LU0130102774.USD","BK4585","LU0528227936.USD","LU0477156797.USD","LU1989764664.SGD","LU1201861249.SGD","LU0477156953.USD","LU1989764748.USD","IQV","LU1201861165.SGD","LU0980610538.SGD","EKG","BK4121","LU0648001328.SGD","LU1791710582.SGD","LU1791710400.SGD","LU0130517989.USD","LU0130103400.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671250761","title":"Centene Corp. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2671250761","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671250761?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:59","pubTimestamp":1790629140,"startTime":"0","endTime":"0","summary":"DJ Centene Corp. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Centene Corp.  rose 1.15% to $62.53 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.77% to 7,683.69 and Dow Jones Industrial Average  falling 0.67% to 51,481.51.The stock's rise snapped a six-day losing streak.Centene Corp. closed 10.20% short of its 52-week high of $69.63, which the company achieved on September 14th.The stock outperformed some of its competitors Monday, as HCA Healthcare Inc.  fell 0.69% to $432.60, IQVIA Holdings Inc.  rose 0.22% to $270.97, and Labcorp Holdings Inc.  fell 0.02% to $309.57.Trading volume  eclipsed its 50-day average volume of 4.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 28, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0187121727.USD","LU1201861249.SGD","LU0114720955.EUR","LU0648000940.SGD","LU1791710400.SGD","LU0985489474.SGD","LU2065171402.SGD","LU0859254822.USD","LU0006061336.USD","LU0310800379.SGD","LU1267930490.SGD","BK4196","LH","LU0868494617.USD","LU0251142724.SGD","IQV","CNC","LU0528227936.USD","SG9999014021.USD","HCA","LU0130517989.USD","LU2362540622.SGD","LU0648001328.SGD","LU1291159041.SGD","LU0048573561.USD","LU2065170008.USD","LU0310799852.SGD","LU2065169927.USD","LU0203347892.USD","HEAL","LU0980610538.SGD","LU2065171311.SGD","LU2357627491.SGD","LU0128525929.USD","LU2237438978.USD","EKG","LU0130518102.USD","BK4530","LU0203345920.USD","LU1150488135.SGD","LU0708994859.HKD","LU0029864427.USD","SG9999014039.USD","CNCG","BK4588","IE00B3S45H60.SGD","IHF","LU1119994496.HKD","LU0878866978.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671254212","title":"France's Genfit H1 Revenue Falls Due to Absence of Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2671254212","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671254212?lang=en_us&edition=fundamental","pubTime":"2026-09-29 02:02","pubTimestamp":1790618522,"startTime":"0","endTime":"0","summary":"France's Genfit H1 revenue falls due to absence of milestone paymentsOverviewFrance biopharma firm's H1 revenue fell yr/yr due to lower milestone paymentsNet loss widened in H1 2026, reflecting higher","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL1N45K0RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130517989.USD","LU1261432733.SGD","LU0130103400.USD","LU0648001328.SGD","LU1791710400.SGD","LU0980610538.SGD","LU0648000940.SGD","IQV","LU1989764748.USD","BK4121","LU0477156953.USD","LU0198837287.USD","EKG","LU1989764664.SGD","HEAL","LU0477156797.USD","LU1201861165.SGD","LU0528227936.USD","BK4585","LU0130102774.USD","LU1201861249.SGD","LU0130518102.USD","LU0882574055.USD","BK4588","BK4530","LU1791710582.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670925843","title":"Charles River price target raised to $330 from $300 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2670925843","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670925843?lang=en_us&edition=fundamental","pubTime":"2026-09-28 21:35","pubTimestamp":1790602515,"startTime":"0","endTime":"0","summary":"BofA analyst Michael Ryskin raised the firm’s price target on Charles River (CRL) to $330 from $300 and keeps a Buy rating on the shares after havi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/charles-river-price-target-raised-to-330-from-300-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/charles-river-price-target-raised-to-330-from-300-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","BK4121","IE00BFMHRM44.USD","LU0757428866.USD","LU1815336091.USD","BK4530","LU0128526141.USD","LU0390134368.USD","BK4585","CRL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234690","title":"Analysts Offer Insights on Healthcare Companies: Xencor (XNCR) and IQVIA Holdings (IQV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234690","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234690?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:32","pubTimestamp":1790595120,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xencor (XNCR) and IQVIA Holdings (IQV) with bullish ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-xencor-xncr-and-iqvia-holdings-iqv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-xencor-xncr-and-iqvia-holdings-iqv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0130518102.USD","LU0198837287.USD","XLV","LU1791710582.SGD","LU1989764748.USD","BK4121","LU0477156953.USD","LU1201861165.SGD","BK4588","HEAL","LU0130102774.USD","LABU","LU0528227936.USD","LU0128526141.USD","LU0477156797.USD","LU0130103400.USD","LU1989764664.SGD","EKG","LU0648000940.SGD","LU0882574055.USD","LU1261432733.SGD","LU0130517989.USD","XNCR","XBI","BK4585","LU1201861249.SGD","BK4137","LU0029874061.USD","LU0980610538.SGD","LU0648001328.SGD","HCSG","BK4581","BK4139","LU1791710400.SGD","BK4530","IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671652032","title":"Strategic Minerals gets $9.2M Department of War funding for UK tungsten project","url":"https://stock-news.laohu8.com/highlight/detail?id=2671652032","media":"Mining","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671652032?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:40","pubTimestamp":1790584800,"startTime":"0","endTime":"0","summary":"Redmoor is Europe’s highest-grade, undeveloped tungsten resource.","market":"us","thumbnail":"https://www.mining.com/wp-content/uploads/2020/05/aerial-view-2129603_1280.jpg","type":0,"news_type":0,"thumbnails":["https://www.mining.com/wp-content/uploads/2020/05/aerial-view-2129603_1280.jpg"],"rights":{"source":"mining_highlight","url":"https://www.mining.com/strategic-minerals-gets-9-2m-department-of-war-funding-for-uk-tungsten-project/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mining.com/strategic-minerals-gets-9-2m-department-of-war-funding-for-uk-tungsten-project/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mining_highlight","symbols":["LU0128526141.USD","BK4109","LU0029874061.USD","BK4121","LU0757428866.USD","BK4585","BK4530","MTX","BK4588","LU0390134368.USD","CRL","IE00BFMHRM44.USD","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670880286","title":"Charles River Laboratories International, Inc. : Jefferies Raises Target Price to $340 from $305","url":"https://stock-news.laohu8.com/highlight/detail?id=2670880286","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670880286?lang=en_us&edition=fundamental","pubTime":"2026-09-28 13:09","pubTimestamp":1790572155,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45I055:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0757428866.USD","CRL","BK4530","LU0128526141.USD","LU0029874061.USD","BK4585","BK4588","IE00BFMHRM44.USD","BK4121","LU1815336091.USD","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670424480","title":"Gartner Inc. Stock Rises 4.8%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2670424480","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670424480?lang=en_us&edition=fundamental","pubTime":"2026-09-26 04:33","pubTimestamp":1790368380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Gartner Inc. advanced 4.8% to $187.90 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.5% to 7,743.41 and the Dow Jones Industrial Average rising 0.9% to 51,828.62.This was the stock's second consecutive day of gains.Gartner Inc. closed 29.3% short of its 52-week high of $265.85, which the company reached on September 26th.The stock outperformed some of its peers, as Trade Desk Inc. Cl A fell 0.2% to $12.60, IQVIA Holdings Inc. fell 1.7% to $270.37, and Omnicom Group Inc. rose 1.94% to $76.15.Trading volume totaled 1.1 million, compared to the 50-day average of 1.3 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130517989.USD","IT","LU1201861165.SGD","LU1548497426.USD","LU2362540622.SGD","LU0154245673.USD","IE00BFXG1179.USD","TTDU","LU0742537680.HKD","LU0731783048.USD","LU2517655374.HKD","LU0321505439.SGD","LU1814569148.SGD","LU1599440770.SGD","EKG","LU0528227936.USD","OMC","BK4530","BK4588","LU0154245756.USD","LU0731783394.SGD","LU1509826696.USD","BK4009","IQV","TTD","LU0477156953.USD","LU0130103400.USD","LU1989764748.USD","LU2362541513.USD","LU1201861249.SGD","BK4528","LU0772969993.USD","LU1481011671.HKD","LU1261432733.SGD","BK4134","LU0882574055.USD","LU2517655028.SGD","BK4613","BK4121","LU0130102774.USD","LU1720051108.HKD","LU2517655291.USD","LU0130518102.USD","LU0477156797.USD","LU0107464264.USD","LU0198837287.USD","HEAL","RSPC","LU0980610538.SGD","LU0648001328.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670425381","title":"Charles River Laboratories's DAS Segment Faces Largest Margin Upside, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670425381","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670425381?lang=en_us&edition=fundamental","pubTime":"2026-09-25 23:12","pubTimestamp":1790349172,"startTime":"0","endTime":"0","summary":"Charles River Laboratories'  Discovery and Safety Assessment segment faces the largest margin upside, as pricing has not been meaningfully factored in, RBC Capital Markets analysts said in a Friday note.Analysts said the company's long-range plan beat consensus expectations but was in line with RBC estimates.The company believes integrating in vitro, in silico, and in vivo evidence to generate more robust decision-making is the future of new approach methodologies, according to RBC.Analysts said that the company's $300 million Create the Future program is a credible margin bridge, while manufacturing expansion expands its reach across the clinical development life cycle.RBC retained an outperform rating on the stock and increased its price target to $322 from $282.Price: 291.92, Change: -2.52, Percent Change: -0.86","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4121","LU0390134368.USD","LU1815336091.USD","LU0757428866.USD","BK4585","CRL","BK4530","LU0029874061.USD","LU0128526141.USD","BK4588","IE00BFMHRM44.USD","BK7095","CRL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670510440","title":"Charles River Labs is Maintained at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2670510440","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670510440?lang=en_us&edition=fundamental","pubTime":"2026-09-25 20:42","pubTimestamp":1790340120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRL/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0390134368.USD","CRL","LU0128526141.USD","LU1815336091.USD","LU0029874061.USD","BK4121","LU0757428866.USD","IE00BFMHRM44.USD","BK4588","BK4530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442708","title":"Charles River price target raised to $295 from $264 at Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442708","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442708?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:30","pubTimestamp":1790335831,"startTime":"0","endTime":"0","summary":"Mizuho raised the firm’s price target on Charles River (CRL) to $295 from $264 and keeps a Neutral rating on the shares following the investor day....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/charles-river-price-target-raised-to-295-from-264-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/charles-river-price-target-raised-to-295-from-264-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFMHRM44.USD","BK4588","BK4585","BK4121","CRL","LU0128526141.USD","LU0390134368.USD","BK4530","LU0757428866.USD","LU1815336091.USD","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670044230","title":"Charles River Laboratories : Deutsche Bank Raises Target Price to $320 from $300","url":"https://stock-news.laohu8.com/highlight/detail?id=2670044230","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670044230?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:07","pubTimestamp":1790334428,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nAQN2MKSQG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4588","LU0390134368.USD","CRL","LU0128526141.USD","BK4530","LU0029874061.USD","BK4121","LU1815336091.USD","LU0757428866.USD","IE00BFMHRM44.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670410219","title":"Crossject Expands Executive Board to Five with Lacombe, Morin, Seltz Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2670410219","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670410219?lang=en_us&edition=fundamental","pubTime":"2026-09-25 13:30","pubTimestamp":1790314241,"startTime":"0","endTime":"0","summary":"Crossject expands executive board to five with Lacombe, Morin, Seltz appointmentsCrossject expanded its Executive Board to five members, appointing Olivier Lacombe, Didier Morin, Lionel Seltz with imm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nNDL7gpL60:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989764748.USD","LU1791710400.SGD","IE00BGHQF748.EUR","LU0130518102.USD","SG9999014005.SGD","LU1261432733.SGD","LU0980610538.SGD","LU1201861165.SGD","NDAQ","IE00BQXX3C00.GBP","BK4121","HEAL","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","LU0528227936.USD","LU0130517989.USD","LU0477156953.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU0648000940.SGD","BCDF","LU2210150020.SGD","LU0198837287.USD","BK4585","EKG","LU1201861249.SGD","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","LU1791710582.SGD","LU0130102774.USD","SG9999014013.SGD","IE00BN0W2V16.EUR","IQV","BK4530","LU1989764664.SGD","IE00BN0W2T93.GBP","LU0130103400.USD","SG9999014039.USD","BK4588","LU0648001328.SGD","LU0882574055.USD","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","LU2095319765.USD","LU0477156797.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":44,"code":"91000000","status":"200"}]}}